Global Blood Therapeutics (GBT) is now part of Pfizer, and we look forward to continuing our mission on behalf of people living with sickle cell disease. The Global Blood Therapeutics page will no longer be active or monitored. Please follow Pfizer for new content.
View Top Employees from Global Blood Therapeutics| Website | http://www.gbt.com |
| Ticker | GBT |
| Funding | $358.7 million |
| Employees | 351 (351 on RocketReach) |
| Founded | 2011 |
| Address | 181 Oyster Point Blvd, South San Francisco, California 94080, US |
| Phone | (650) 741-7700 |
| Fax | (650) 741-7701 |
| Technologies |
JavaScript,
HTML,
PHP
+75 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Genetics, Health Care, Medical, Therapeutics |
| Web Rank | 3 Million |
| Keywords | Gbt 440 How Much Should I Take, Gbt Investor Relations |
| Competitors | Acceleron Pharma, Atreca, Inc., Enterome, Orphazyme A/S, Xenon Pharmaceuticals Inc. |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Global Blood Therapeutics employee's phone or email?
Global Blood Therapeutics Questions
Ken Bridges is the Vice President of Global Blood Therapeutics.
351 people are employed at Global Blood Therapeutics.
Global Blood Therapeutics is based in South San Francisco, California.
The NAICS codes for Global Blood Therapeutics are [3254, 32541, 32, 325, 541, 54].
The SIC codes for Global Blood Therapeutics are [2834, 28, 283, 87].
Top Global Blood Therapeutics Employees
-
45
-
ViewSteven Immergut
Senior Vice President, Head of Corporate Communications and Investor Relations at Global Blood Therapeutics
Washington, District of Columbia, United States55+ -
ViewMiguel Carrillo
Senior Vice President Finance at Global Blood Therapeutics
San Francisco, CA, US23 -
ViewDeborah Arrindell
Vice President-Pharmacovigilance at Global Blood Therapeutics
Los Angeles, CA, US55+
Related Companies
